ArticleJournal of thoracic disease2020

The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer.

Hyun-Il Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.